Skip to content
Clinical Trials – home
Johnson And Johnson Enterprise Innovation Inc.
Sponsor

Johnson And Johnson Enterprise Innovation Inc.

United States 1 Johnson And Johnson Plaza, 08933-0001, United States

About the sponsor

Clinical research includes advanced non-small cell lung cancer and locally advanced unresectable stage III NSCLC, with interest in combining radiotherapy with systemic and local treatment approaches.

  • Radioenhancing cancer therapy
  • Chemoradiation
  • Immune checkpoint inhibition
  • Durvalumab

The portfolio reflects a focus on treatment strategies for lung tumors that are difficult to control with standard local therapy alone.

About Specializations

Johnson And Johnson Enterprise Innovation Inc. runs clinical trials in conditions such as Head and neck cancer, Non-small cell lung cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study of NBTXR3 and Cetuximab for Elderly Patients with Advanced Head and Neck Cancer Ineligible for Platinum Chemotherapy

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Johnson And Johnson Enterprise Innovation Inc.

Study of JNJ-90301900 with Chemoradiation and Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Hafnium oxide
  • Sponsor:Johnson And Johnson Enterprise Innovation Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.